Bourgeon Capital Management LLC Viracta Therapeutics, Inc. Transaction History

Bourgeon Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$0.89 - $2.13 $1,335 - $3,195	-1,500 Reduced 16.67%	7,500 $10,000
Q1 2023 Apr 17, 2023	SELL	$1.38 - $2.29 $11,730 - $19,465	-8,500 Reduced 48.57%	9,000 $14,000
Q4 2022 Jan 20, 2023	SELL	$1.26 - $4.38 $3,780 - $13,140	-3,000 Reduced 14.63%	17,500 $0
Q4 2021 Jan 31, 2022	BUY	$3.37 - $7.91 $5,897 - $13,842	1,750 Added 9.33%	20,500 $75,000
Q3 2021 Nov 09, 2021	BUY	$7.84 - $12.53 $143,080 - $228,672	18,250 Added 3650.0%	18,750 $150,000
Q2 2021 Jul 19, 2021	SELL	$7.55 - $12.95 $3,775 - $6,475	-500 Reduced 50.0%	500 $6,000
Q1 2021 May 13, 2021	BUY	$7.58 - $18.67 $7,580 - $18,670	1,000 New	1,000 $9,000

3.66M

1.8K

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $1.13M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.